GRCE

Grace Therapeutics (GRCE)

About Grace Therapeutics (GRCE)

Grace Therapeutics, Inc. is a biopharmaceutical company, which engages in the development and commercialization of pharmaceutical applications of its licensed rights for cardiovascular diseases. It focuses on the research of prescription drugs using omega-3, fatty acids derived from krill oil. The company was founded by Henri Harland and Pierre Lemieux on February 1, 2002 and is headquartered in Princeton, NJ.

Details

Daily high
$3.79
Daily low
$3.48
Price at open
$3.48
52 Week High
$5.18
52 Week Low
$1.98
Market cap
55.6M
Dividend yield
0.00%
Volume
312,959
Avg. volume
881,662
P/E ratio
-9.96

Grace Therapeutics News

Details

Daily high
$3.79
Daily low
$3.48
Price at open
$3.48
52 Week High
$5.18
52 Week Low
$1.98
Market cap
55.6M
Dividend yield
0.00%
Volume
312,959
Avg. volume
881,662
P/E ratio
-9.96